 | • レポートコード：GIR-2104Z06241 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ガバペンチン薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ガバペンチン薬の種類別市場規模（カプセル、錠剤、経口液剤）、用途別市場規模（成人の帯状疱疹後神経痛、部分てんかん発作、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ガバペンチン薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Depomed、Apotex、Teva、Acella Pharmaceuticals、Taro、Sun Pharmaceutical、Glenmark、Amneal Pharmaceuticals、Aurobindo Pharma、Zydus Pharmaceuticals、Hi-Tech Pharmaceuticals、Marksans Pharma、Mylan、InvaGen Pharmaceuticals、Alkem Laboratories、Tris Pharma、ACI HealthCare Limited、Jiangsu Hengrui Medicine、CSPC Ouyi Pharmaceutical、Sciegen Pharmaceuticals、Epic Pharma、Lupin Limited ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：カプセル、錠剤、経口液剤 ・用途別分析2016年-2026年：成人の帯状疱疹後神経痛、部分てんかん発作、その他 ・ガバペンチン薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ガバペンチン薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ガバペンチン薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ガバペンチン薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ガバペンチン薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Gabapentin Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Gabapentin Drug size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Gabapentin Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Gabapentin Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Capsule
Tablet
Oral Solution
Market segment by Application can be divided into
Postherpetic Neuralgia in Adults
Partial Onset Seizures
Others
The key market players for global Gabapentin Drug market are listed below:
Pfizer
Depomed
Apotex
Teva
Acella Pharmaceuticals
Taro
Sun Pharmaceutical
Glenmark
Amneal Pharmaceuticals
Aurobindo Pharma
Zydus Pharmaceuticals
Hi-Tech Pharmaceuticals
Marksans Pharma
Mylan
InvaGen Pharmaceuticals
Alkem Laboratories
Tris Pharma
ACI HealthCare Limited
Jiangsu Hengrui Medicine
CSPC Ouyi Pharmaceutical
Sciegen Pharmaceuticals
Epic Pharma
Lupin Limited
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Gabapentin Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gabapentin Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Capsule
1.2.3 Tablet
1.2.4 Oral Solution
1.3 Market Analysis by Application
1.3.1 Overview: Global Gabapentin Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Postherpetic Neuralgia in Adults
1.3.3 Partial Onset Seizures
1.3.4 Others
1.4 Global Gabapentin Drug Market Size & Forecast
1.4.1 Global Gabapentin Drug Sales in Value (2016-2026))
1.4.2 Global Gabapentin Drug Sales in Volume (2016-2026)
1.4.3 Global Gabapentin Drug Price by Type (2016-2026) & (USD/Unit)
1.5 Global Gabapentin Drug Production Capacity Analysis
1.5.1 Global Gabapentin Drug Total Production Capacity (2016-2026)
1.5.2 Global Gabapentin Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gabapentin Drug Market Drivers
1.6.2 Gabapentin Drug Market Restraints
1.6.3 Gabapentin Drug Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Gabapentin Drug Product and Services
2.1.4 Pfizer Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Depomed
2.2.1 Depomed Details
2.2.2 Depomed Major Business
2.2.3 Depomed Gabapentin Drug Product and Services
2.2.4 Depomed Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Apotex
2.3.1 Apotex Details
2.3.2 Apotex Major Business
2.3.3 Apotex Gabapentin Drug Product and Services
2.3.4 Apotex Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business
2.4.3 Teva Gabapentin Drug Product and Services
2.4.4 Teva Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Acella Pharmaceuticals
2.5.1 Acella Pharmaceuticals Details
2.5.2 Acella Pharmaceuticals Major Business
2.5.3 Acella Pharmaceuticals Gabapentin Drug Product and Services
2.5.4 Acella Pharmaceuticals Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Taro
2.6.1 Taro Details
2.6.2 Taro Major Business
2.6.3 Taro Gabapentin Drug Product and Services
2.6.4 Taro Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Sun Pharmaceutical
2.7.1 Sun Pharmaceutical Details
2.7.2 Sun Pharmaceutical Major Business
2.7.3 Sun Pharmaceutical Gabapentin Drug Product and Services
2.7.4 Sun Pharmaceutical Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Glenmark
2.8.1 Glenmark Details
2.8.2 Glenmark Major Business
2.8.3 Glenmark Gabapentin Drug Product and Services
2.8.4 Glenmark Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Amneal Pharmaceuticals
2.9.1 Amneal Pharmaceuticals Details
2.9.2 Amneal Pharmaceuticals Major Business
2.9.3 Amneal Pharmaceuticals Gabapentin Drug Product and Services
2.9.4 Amneal Pharmaceuticals Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Aurobindo Pharma
2.10.1 Aurobindo Pharma Details
2.10.2 Aurobindo Pharma Major Business
2.10.3 Aurobindo Pharma Gabapentin Drug Product and Services
2.10.4 Aurobindo Pharma Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Zydus Pharmaceuticals
2.11.1 Zydus Pharmaceuticals Details
2.11.2 Zydus Pharmaceuticals Major Business
2.11.3 Zydus Pharmaceuticals Gabapentin Drug Product and Services
2.11.4 Zydus Pharmaceuticals Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Hi-Tech Pharmaceuticals
2.12.1 Hi-Tech Pharmaceuticals Details
2.12.2 Hi-Tech Pharmaceuticals Major Business
2.12.3 Hi-Tech Pharmaceuticals Gabapentin Drug Product and Services
2.12.4 Hi-Tech Pharmaceuticals Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Marksans Pharma
2.13.1 Marksans Pharma Details
2.13.2 Marksans Pharma Major Business
2.13.3 Marksans Pharma Gabapentin Drug Product and Services
2.13.4 Marksans Pharma Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Mylan
2.14.1 Mylan Details
2.14.2 Mylan Major Business
2.14.3 Mylan Gabapentin Drug Product and Services
2.14.4 Mylan Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 InvaGen Pharmaceuticals
2.15.1 InvaGen Pharmaceuticals Details
2.15.2 InvaGen Pharmaceuticals Major Business
2.15.3 InvaGen Pharmaceuticals Gabapentin Drug Product and Services
2.15.4 InvaGen Pharmaceuticals Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Alkem Laboratories
2.16.1 Alkem Laboratories Details
2.16.2 Alkem Laboratories Major Business
2.16.3 Alkem Laboratories Gabapentin Drug Product and Services
2.16.4 Alkem Laboratories Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Tris Pharma
2.17.1 Tris Pharma Details
2.17.2 Tris Pharma Major Business
2.17.3 Tris Pharma Gabapentin Drug Product and Services
2.17.4 Tris Pharma Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.18 ACI HealthCare Limited
2.18.1 ACI HealthCare Limited Details
2.18.2 ACI HealthCare Limited Major Business
2.18.3 ACI HealthCare Limited Gabapentin Drug Product and Services
2.18.4 ACI HealthCare Limited Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.19 Jiangsu Hengrui Medicine
2.19.1 Jiangsu Hengrui Medicine Details
2.19.2 Jiangsu Hengrui Medicine Major Business
2.19.3 Jiangsu Hengrui Medicine Gabapentin Drug Product and Services
2.19.4 Jiangsu Hengrui Medicine Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.20 CSPC Ouyi Pharmaceutical
2.20.1 CSPC Ouyi Pharmaceutical Details
2.20.2 CSPC Ouyi Pharmaceutical Major Business
2.20.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Product and Services
2.20.4 CSPC Ouyi Pharmaceutical Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.21 Sciegen Pharmaceuticals
2.21.1 Sciegen Pharmaceuticals Details
2.21.2 Sciegen Pharmaceuticals Major Business
2.21.3 Sciegen Pharmaceuticals Gabapentin Drug Product and Services
2.21.4 Sciegen Pharmaceuticals Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.22 Epic Pharma
2.22.1 Epic Pharma Details
2.22.2 Epic Pharma Major Business
2.22.3 Epic Pharma Gabapentin Drug Product and Services
2.22.4 Epic Pharma Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.23 Lupin Limited
2.23.1 Lupin Limited Details
2.23.2 Lupin Limited Major Business
2.23.3 Lupin Limited Gabapentin Drug Product and Services
2.23.4 Lupin Limited Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Gabapentin Drug Sales by Manufacturer
3.1 Global Gabapentin Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Gabapentin Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Gabapentin Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Gabapentin Drug Manufacturer Market Share
3.4.2 Top 6 Gabapentin Drug Manufacturer Market Share
3.5 Global Gabapentin Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Gabapentin Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Gabapentin Drug Market Size by Region
4.1.1 Global Gabapentin Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Gabapentin Drug Revenue by Region (2016-2026)
4.2 North America Gabapentin Drug Revenue (2016-2026)
4.3 Europe Gabapentin Drug Revenue (2016-2026)
4.4 Asia-Pacific Gabapentin Drug Revenue (2016-2026)
4.5 South America Gabapentin Drug Revenue (2016-2026)
4.6 Middle East and Africa Gabapentin Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Gabapentin Drug Sales in Volume by Type (2016-2026)
5.2 Global Gabapentin Drug Revenue by Type (2016-2026)
5.3 Global Gabapentin Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Gabapentin Drug Sales in Volume by Application (2016-2026)
6.2 Global Gabapentin Drug Revenue by Application (2016-2026)
6.3 Global Gabapentin Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Gabapentin Drug Sales by Type (2016-2026)
7.2 North America Gabapentin Drug Sales by Application (2016-2026)
7.3 North America Gabapentin Drug Market Size by Country
7.3.1 North America Gabapentin Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Gabapentin Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Gabapentin Drug Sales by Type (2016-2026)
8.2 Europe Gabapentin Drug Sales by Application (2016-2026)
8.3 Europe Gabapentin Drug Market Size by Country
8.3.1 Europe Gabapentin Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Gabapentin Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Gabapentin Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Gabapentin Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Gabapentin Drug Market Size by Region
9.3.1 Asia-Pacific Gabapentin Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Gabapentin Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Gabapentin Drug Sales by Type (2016-2026)
10.2 South America Gabapentin Drug Sales by Application (2016-2026)
10.3 South America Gabapentin Drug Market Size by Country
10.3.1 South America Gabapentin Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Gabapentin Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gabapentin Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Gabapentin Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Gabapentin Drug Market Size by Country
11.3.1 Middle East & Africa Gabapentin Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Gabapentin Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Gabapentin Drug Typical Distributors
12.3 Gabapentin Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Gabapentin Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Gabapentin Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Gabapentin Drug Product and Services
Table 6. Pfizer Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Depomed Basic Information, Manufacturing Base and Competitors
Table 8. Depomed Major Business
Table 9. Depomed Gabapentin Drug Product and Services
Table 10. Depomed Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Apotex Basic Information, Manufacturing Base and Competitors
Table 12. Apotex Major Business
Table 13. Apotex Gabapentin Drug Product and Services
Table 14. Apotex Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Teva Basic Information, Manufacturing Base and Competitors
Table 16. Teva Major Business
Table 17. Teva Gabapentin Drug Product and Services
Table 18. Teva Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Acella Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Acella Pharmaceuticals Major Business
Table 21. Acella Pharmaceuticals Gabapentin Drug Product and Services
Table 22. Acella Pharmaceuticals Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Taro Basic Information, Manufacturing Base and Competitors
Table 24. Taro Major Business
Table 25. Taro Gabapentin Drug Product and Services
Table 26. Taro Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 28. Sun Pharmaceutical Major Business
Table 29. Sun Pharmaceutical Gabapentin Drug Product and Services
Table 30. Sun Pharmaceutical Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Glenmark Basic Information, Manufacturing Base and Competitors
Table 32. Glenmark Major Business
Table 33. Glenmark Gabapentin Drug Product and Services
Table 34. Glenmark Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Amneal Pharmaceuticals Major Business
Table 37. Amneal Pharmaceuticals Gabapentin Drug Product and Services
Table 38. Amneal Pharmaceuticals Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 40. Aurobindo Pharma Major Business
Table 41. Aurobindo Pharma Gabapentin Drug Product and Services
Table 42. Aurobindo Pharma Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Zydus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Zydus Pharmaceuticals Major Business
Table 45. Zydus Pharmaceuticals Gabapentin Drug Product and Services
Table 46. Zydus Pharmaceuticals Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Hi-Tech Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 48. Hi-Tech Pharmaceuticals Major Business
Table 49. Hi-Tech Pharmaceuticals Gabapentin Drug Product and Services
Table 50. Hi-Tech Pharmaceuticals Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Marksans Pharma Basic Information, Manufacturing Base and Competitors
Table 52. Marksans Pharma Major Business
Table 53. Marksans Pharma Gabapentin Drug Product and Services
Table 54. Marksans Pharma Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Mylan Basic Information, Manufacturing Base and Competitors
Table 56. Mylan Major Business
Table 57. Mylan Gabapentin Drug Product and Services
Table 58. Mylan Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. InvaGen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. InvaGen Pharmaceuticals Major Business
Table 61. InvaGen Pharmaceuticals Gabapentin Drug Product and Services
Table 62. InvaGen Pharmaceuticals Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Alkem Laboratories Basic Information, Manufacturing Base and Competitors
Table 64. Alkem Laboratories Major Business
Table 65. Alkem Laboratories Gabapentin Drug Product and Services
Table 66. Alkem Laboratories Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Tris Pharma Basic Information, Manufacturing Base and Competitors
Table 68. Tris Pharma Major Business
Table 69. Tris Pharma Gabapentin Drug Product and Services
Table 70. Tris Pharma Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. ACI HealthCare Limited Basic Information, Manufacturing Base and Competitors
Table 72. ACI HealthCare Limited Major Business
Table 73. ACI HealthCare Limited Gabapentin Drug Product and Services
Table 74. ACI HealthCare Limited Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 76. Jiangsu Hengrui Medicine Major Business
Table 77. Jiangsu Hengrui Medicine Gabapentin Drug Product and Services
Table 78. Jiangsu Hengrui Medicine Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. CSPC Ouyi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. CSPC Ouyi Pharmaceutical Major Business
Table 81. CSPC Ouyi Pharmaceutical Gabapentin Drug Product and Services
Table 82. CSPC Ouyi Pharmaceutical Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Sciegen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 84. Sciegen Pharmaceuticals Major Business
Table 85. Sciegen Pharmaceuticals Gabapentin Drug Product and Services
Table 86. Sciegen Pharmaceuticals Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Epic Pharma Basic Information, Manufacturing Base and Competitors
Table 88. Epic Pharma Major Business
Table 89. Epic Pharma Gabapentin Drug Product and Services
Table 90. Epic Pharma Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Lupin Limited Basic Information, Manufacturing Base and Competitors
Table 92. Lupin Limited Major Business
Table 93. Lupin Limited Gabapentin Drug Product and Services
Table 94. Lupin Limited Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 95. Global Gabapentin Drug Sales by Manufacturer (2019-2021e) & (K Units)
Table 96. Global Gabapentin Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 97. Market Position of Manufacturers in Gabapentin Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 98. Global Gabapentin Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 99. Head Office and Gabapentin Drug Production Site of Key Manufacturer
Table 100. Global Gabapentin Drug Sales by Region (2016-2021e) & (K Units)
Table 101. Global Gabapentin Drug Sales by Region (2021-2026) & (K Units)
Table 102. Global Gabapentin Drug Revenue by Region (2016-2021e) & (USD Million)
Table 103. Global Gabapentin Drug Revenue by Region (2021-2026) & (USD Million)
Table 104. Global Gabapentin Drug Sales by Type (2016-2021e) & (K Units)
Table 105. Global Gabapentin Drug Sales by Type (2021-2026) & (K Units)
Table 106. Global Gabapentin Drug Revenue by Type (2016-2021e) & (USD Million)
Table 107. Global Gabapentin Drug Revenue by Type (2021-2026) & (USD Million)
Table 108. Global Gabapentin Drug Price by Type (2016-2021e) & (USD/Unit)
Table 109. Global Gabapentin Drug Price by Type (2021-2026) & (USD/Unit)
Table 110. Global Gabapentin Drug Sales by Application (2016-2021e) & (K Units)
Table 111. Global Gabapentin Drug Sales by Application (2021-2026) & (K Units)
Table 112. Global Gabapentin Drug Revenue by Application (2016-2021e) & (USD Million)
Table 113. Global Gabapentin Drug Revenue by Application (2021-2026) & (USD Million)
Table 114. Global Gabapentin Drug Price by Application (2016-2021e) & (USD/Unit)
Table 115. Global Gabapentin Drug Price by Application (2021-2026) & (USD/Unit)
Table 116. North America Gabapentin Drug Sales by Country (2016-2021e) & (K Units)
Table 117. North America Gabapentin Drug Sales by Country (2021-2026) & (K Units)
Table 118. North America Gabapentin Drug Revenue by Country (2016-2021e) & (USD Million)
Table 119. North America Gabapentin Drug Revenue by Country (2021-2026) & (USD Million)
Table 120. North America Gabapentin Drug Sales by Type (2016-2021e) & (K Units)
Table 121. North America Gabapentin Drug Sales by Type (2021-2026) & (K Units)
Table 122. North America Gabapentin Drug Sales by Application (2016-2021e) & (K Units)
Table 123. North America Gabapentin Drug Sales by Application (2021-2026) & (K Units)
Table 124. Europe Gabapentin Drug Sales by Country (2016-2021e) & (K Units)
Table 125. Europe Gabapentin Drug Sales by Country (2021-2026) & (K Units)
Table 126. Europe Gabapentin Drug Revenue by Country (2016-2021e) & (USD Million)
Table 127. Europe Gabapentin Drug Revenue by Country (2021-2026) & (USD Million)
Table 128. Europe Gabapentin Drug Sales by Type (2016-2021e) & (K Units)
Table 129. Europe Gabapentin Drug Sales by Type (2021-2026) & (K Units)
Table 130. Europe Gabapentin Drug Sales by Application (2016-2021e) & (K Units)
Table 131. Europe Gabapentin Drug Sales by Application (2021-2026) & (K Units)
Table 132. Asia-Pacific Gabapentin Drug Sales by Region (2016-2021e) & (K Units)
Table 133. Asia-Pacific Gabapentin Drug Sales by Region (2021-2026) & (K Units)
Table 134. Asia-Pacific Gabapentin Drug Revenue by Region (2016-2021e) & (USD Million)
Table 135. Asia-Pacific Gabapentin Drug Revenue by Region (2021-2026) & (USD Million)
Table 136. Asia-Pacific Gabapentin Drug Sales by Type (2016-2021e) & (K Units)
Table 137. Asia-Pacific Gabapentin Drug Sales by Type (2021-2026) & (K Units)
Table 138. Asia-Pacific Gabapentin Drug Sales by Application (2016-2021e) & (K Units)
Table 139. Asia-Pacific Gabapentin Drug Sales by Application (2021-2026) & (K Units)
Table 140. South America Gabapentin Drug Sales by Country (2016-2021e) & (K Units)
Table 141. South America Gabapentin Drug Sales by Country (2021-2026) & (K Units)
Table 142. South America Gabapentin Drug Revenue by Country (2016-2021e) & (USD Million)
Table 143. South America Gabapentin Drug Revenue by Country (2021-2026) & (USD Million)
Table 144. South America Gabapentin Drug Sales by Type (2016-2021e) & (K Units)
Table 145. South America Gabapentin Drug Sales by Type (2021-2026) & (K Units)
Table 146. South America Gabapentin Drug Sales by Application (2016-2021e) & (K Units)
Table 147. South America Gabapentin Drug Sales by Application (2021-2026) & (K Units)
Table 148. Middle East & Africa Gabapentin Drug Sales by Country (2016-2021e) & (K Units)
Table 149. Middle East & Africa Gabapentin Drug Sales by Country (2021-2026) & (K Units)
Table 150. Middle East & Africa Gabapentin Drug Revenue by Country (2016-2021e) & (USD Million)
Table 151. Middle East & Africa Gabapentin Drug Revenue by Country (2021-2026) & (USD Million)
Table 152. Middle East & Africa Gabapentin Drug Sales by Type (2016-2021e) & (K Units)
Table 153. Middle East & Africa Gabapentin Drug Sales by Type (2021-2026) & (K Units)
Table 154. Middle East & Africa Gabapentin Drug Sales by Application (2016-2021e) & (K Units)
Table 155. Middle East & Africa Gabapentin Drug Sales by Application (2021-2026) & (K Units)
Table 156. Direct Channel Pros & Cons
Table 157. Indirect Channel Pros & Cons
Table 158. Gabapentin Drug Typical Distributors
Table 159. Gabapentin Drug Typical Customers
List of Figures
Figure 1. Gabapentin Drug Picture
Figure 2. Global Gabapentin Drug Sales Market Share by Type in 2020
Figure 3. Capsule
Figure 4. Tablet
Figure 5. Oral Solution
Figure 6. Global Gabapentin Drug Sales Market Share by Application in 2020
Figure 7. Postherpetic Neuralgia in Adults
Figure 8. Partial Onset Seizures
Figure 9. Others
Figure 10. Global Gabapentin Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Gabapentin Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Gabapentin Drug Sales (2016-2026) & (K Units)
Figure 32. Global Gabapentin Drug Production Capacity (2016-2026) & (K Units)
Figure 33. Global Gabapentin Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Gabapentin Drug Market Drivers
Figure 35. Gabapentin Drug Market Restraints
Figure 36. Gabapentin Drug Market Trends
Figure 37. Global Gabapentin Drug Sales Market Share by Manufacturer in 2020
Figure 38. Global Gabapentin Drug Revenue Market Share by Manufacturer in 2020
Figure 39. Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Gabapentin Drug Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Gabapentin Drug Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Gabapentin Drug Sales Market Share by Region (2016-2026)
Figure 43. Global Gabapentin Drug Revenue Market Share by Region (2016-2026)
Figure 44. North America Gabapentin Drug Revenue (2016-2026) & (USD Million)
Figure 45. Europe Gabapentin Drug Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Gabapentin Drug Revenue (2016-2026) & (USD Million)
Figure 47. South America Gabapentin Drug Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Gabapentin Drug Revenue (2016-2026) & (USD Million)
Figure 49. Global Gabapentin Drug Sales Market Share by Type (2016-2026)
Figure 50. Global Gabapentin Drug Revenue Market Share by Type (2016-2026)
Figure 51. Global Gabapentin Drug Price by Type (2016-2026) & (USD/Unit)
Figure 52. Global Gabapentin Drug Sales Market Share by Application (2016-2026)
Figure 53. Global Gabapentin Drug Revenue Market Share by Application (2016-2026)
Figure 54. Global Gabapentin Drug Price by Application (2016-2026) & (USD/Unit)
Figure 55. North America Gabapentin Drug Sales Market Share by Country (2016-2026)
Figure 56. North America Gabapentin Drug Revenue Market Share by Country (2016-2026)
Figure 57. North America Gabapentin Drug Sales Market Share by Type (2016-2026)
Figure 58. North America Gabapentin Drug Sales Market Share by Application (2016-2026)
Figure 59. Europe Gabapentin Drug Sales Market Share by Country (2016-2026)
Figure 60. Europe Gabapentin Drug Revenue Market Share by Country (2016-2026)
Figure 61. Europe Gabapentin Drug Sales Market Share by Type (2016-2026)
Figure 62. Europe Gabapentin Drug Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Gabapentin Drug Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Gabapentin Drug Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Gabapentin Drug Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Gabapentin Drug Sales Market Share by Application (2016-2026)
Figure 67. South America Gabapentin Drug Sales Market Share by Country (2016-2026)
Figure 68. South America Gabapentin Drug Revenue Market Share by Country (2016-2026)
Figure 69. South America Gabapentin Drug Sales Market Share by Type (2016-2026)
Figure 70. South America Gabapentin Drug Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Gabapentin Drug Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Gabapentin Drug Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Gabapentin Drug Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Gabapentin Drug Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の薬物検査用口腔液市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Test Oral Fluid Market The global Drug Test Oral Fluid market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report m…- 世界のタミフル（オセルタミビル）薬市場 2021：企業別、地域別、種類・用途別 The Tamiflu (Oseltamivir) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界の抗口腔粘膜炎薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti–Oral Mucositis Drug Market The global Anti–Oral Mucositis Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の抗口腔粘膜炎薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti–Oral Mucositis Drug Market The global Anti–Oral Mucositis Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
- 世界のアレルギー性鼻炎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Allergy Rhinitis Drug Market The global Allergy Rhinitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report…